Threshold Pharmaceuticals should be bought ahead of data,# Stock
l*0
1 楼
Threshold Pharmaceuticals should be bought ahead of data, says Stifel.
Stifel expects Threshold to report positive data at the end of May on its TH
-302 for the treatment of glioblastoma and multiple myeloma. The firm thinks
this is an ideal time to buy the stock.
Stifel expects Threshold to report positive data at the end of May on its TH
-302 for the treatment of glioblastoma and multiple myeloma. The firm thinks
this is an ideal time to buy the stock.